Tsp Capital Management Group, LLC Celldex Therapeutics, Inc. Transaction History
Tsp Capital Management Group, LLC
- $264 Million
- Q4 2024
A detailed history of Tsp Capital Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 223,343 shares of CLDX stock, worth $4.58 Million. This represents 2.14% of its overall portfolio holdings.
Number of Shares
223,343
Previous 247,820
9.88%
Holding current value
$4.58 Million
Previous $8.42 Million
32.97%
% of portfolio
2.14%
Previous 2.89%
Shares
23 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$184 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$104 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$96.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$79.6 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$76.9 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $959M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...